HRT Financial
XGN icon

HRT Financial’s Exagen XGN Stock Holding History

HRT Financial’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74K Buy
+16,097
New +$60.6K ﹤0.01% 3689
2026
Q1 		– Sell
-69,725
Closed -$423K – 4869
2025
Q4 		$423K Buy
+69,725
New +$635K ﹤0.01% 2196

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
Silvercrest Asset Management
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

HRT Financial's XGN Position: Q2 2026 in Review

HRT Financial opened a new position in Exagen (XGN) in Q2 2026: 16,097 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #3689 among its holdings. This is a return to the name: HRT Financial previously reported a position in XGN as recently as Q4 2025.

HRT Financial first reported a position in XGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $423K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • HRT Financial held 16,097 shares of Exagen worth $74K as of Q2 2026.
  • Exagen was a new HRT Financial position in Q2 2026.
  • Exagen made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3689 holding.
  • HRT Financial first reported a position in Exagen in Q4 2025 and has held it in 2 quarters since.
  • HRT Financial's Exagen position peaked at $423K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.